Anti-cytokine therapy in the treatment of psoriasis

► Psoriasis is a Th17-mediated disease. ► Currently available psoriasis therapies target TNF-α and IL-12 and IL-23. ► Therapies targeting the Th17 pathway are currently in phase 3 studies.